0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo]

50 MG/ML · Prefilled Syringe · injection

A form of adalimumab-adbm →

0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] — Tumor necrosis factor alpha (TNF-alpha) inhibitors. Strength, form, class, interactions & more.

0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo]

Active ingredient

adalimumab-adbm →

Classification

Tumor necrosis factor alpha (TNF-alpha) inhibitorsTumor Necrosis Factor Blocker

Drug interactions

Adalimumab-adbm has several drug interactions that may increase the risk of serious infections or require monitoring of concomitant medications.

  • majorabatacept — Increased risk of serious infection.
  • majoranakinra — Increased risk of serious infection.
  • majorlive vaccines — Avoid use with CYLTEZO.
  • moderatemethotrexate — No need for dose adjustment of either CYLTEZO or MTX.
  • moderateCYP450 substrates — Monitoring of effect or drug concentration is recommended.

Real-world adverse events (FAERS)

Device Malfunction20Injection Site Pain13Drug Ineffective12Wrong Technique in Product Usage Process10Injection Site Haemorrhage9Pain9Haemorrhage8Off Label Use8

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →